Assembly BillFailedBusiness and Professions
AB 1081: On-sale general public premises: drug testing devices.
What AB 1081 does, verified February 3, 2026
<p>This bill would amend the state's laws regarding alcoholic beverages to require on-sale general public premises to offer for sale drug testing devices to customers. The devices are designed to detect the presence of controlled substances in drinks, such as flunitrazepam, ketamine, and gamma hydroxybutyric acid. The bill would also add carfentanil and fentanyl to the list of controlled substances that the devices are intended to detect. The cost of the devices would be based on the wholesale cost and would not exceed a reasonable amount.</p>
Bill journey
✓IntroducedComplete
2In CommitteeCurrent
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. (2026-02-02)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions6 total · showing 5
| Feb. 02, 2026 | From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. |
| Jan. 31, 2026 | Died pursuant to Art. IV, Sec. 10(c) of the Constitution. |
| Apr. 02, 2025 | In committee: Hearing postponed by committee. |
| Mar. 10, 2025 | Referred to Com. on G.O. |
| Feb. 21, 2025 | From printer. May be heard in committee March 23. |
Latest bill textIntroduced version, February 20, 2025 · 563 words
CALIFORNIA LEGISLATURE— 2025–2026 REGULAR SESSION
Assembly Bill
No. 1081
| Introduced by Assembly Member Macedo |
February 20, 2025 |
An act to amend Section 25624 of the Business and Professions Code, relating to alcoholic beverages.
LEGISLATIVE COUNSEL'S DIGEST
AB 1081, as introduced, Macedo. On-sale general public premises: drug testing devices.
The Alcoholic Beverage Control Act, administered by the Department of Alcoholic Beverage Control, regulates the application for, the issuance of, the suspension of and the conditions imposed upon various alcoholic beverage licenses. The act requires an applicant for a new permanent on-sale general public premises (Type 48) license or the holder of an existing Type 48 license to offer for sale to their customers drug testing devices at a cost not to exceed a reasonable amount based on the wholesale cost of those devices. The act defines “drug testing devices” for this purpose to mean specified devices designed to detect the presence of controlled substances in a drink. The act defines “controlled substances,” for these purposes, to include specified substances, including, but not limited to, flunitrazepam, ketamine, and gamma hydroxybutyric acid, as provided.
This bill would additionally specify that, for the above-described purposes, the definition of “controlled substances” also includes carfentanil and fentanyl.
The people of the State of California do enact as follows:
SECTION 1.
Section 25624 of the Business and Professions Code is amended to read:25624.
(a) For purposes of this section, the following definitions apply:(1) “Drug testing devices” means test strips, stickers, straws, and other devices designed to detect the presence of controlled substances in a drink.
(2) “Controlled substances” includes, but is not limited to, carfentanil, fentanyl, flunitrazepam, ketamine, and gamma hydroxybutyric acid, also known by other names, including GHB, gamma hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium oxybate, and sodium oxybutyrate.
(b) An applicant for a new permanent on-sale general public premises (Type 48) license or the holder of an existing Type 48 license shall offer for sale to their customers drug testing devices at a cost not to exceed a reasonable amount based on the wholesale cost of those devices.
(c) A licensee subject to subdivision (b) shall post the following notice in a prominent and conspicuous location:
“Don’t get roofied! Drink lids and drink spiking drug test kits available here. Ask a staff member for details.”
(d) This section does not prevent a Type 48 licensee from offering drug testing devices to their customers free of charge.
(e) A Type 48 licensee shall not be held liable for a defective test or inaccurate test result, including, but not limited to, a false positive or false negative test result.
(f) A Type 48 licensee shall ensure that all testing devices offered to customers have not exceeded their expiration date or recommended period of use, according to the product label, product packaging, or otherwise recommended by the manufacturer.
(g) Notwithstanding Section 25617, a violation of this section is not a crime.
(h) The department shall post on its internet website a link to a page that contains information about the requirements of this section, including, but not limited to, the signage that is required to be posted and the types of drug testing devices that are required to be available on a Type 48 licensed premises.
(i) This section shall be operative on July 1, 2024, and shall be repealed on January 1, 2027.
Text of AB 1081 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions